Expanding clinical trials to underserved patients depends on resilient, flexible supply chains that overcome geography, infrastructure, and logistical challenges.
- Making AI Work For Clinical Trial Supply
- Compliance, Costs, And Site Readiness In CAR-T Clinical Trials
- Managing Operational Challenges In CAR-T Clinical Trial Logistics
- Why Your QMS Is Failing (And How Predictive Analytics Can Save Your Next Audit)
- Digital And AI As Accelerators Of Clinical Supply Strategy
- Digital Isn't The Strategy: What Actually Drives Value In Clinical Supply Transformation
- Why Lean Clinical Teams Often Create Fragile Clinical Supply Chains
- The Clinical Supply Risk In Pharma's PE Boom
ON-DEMAND WEBINARS
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.
This webinar discusses the types of master protocols and how configurable, modern RTSM systems enable fast and seamless mid-study changes to help you efficiently run your master protocol study.
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
![7 Seven Tips GettyImages-1450702003]( "7 Key Considerations For Designing The Optimal IRT/RTSM")
7 Key Considerations For Designing The Optimal IRT/RTSMSponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
![Vials pharma manufacturing GettyImages-618518692]( "Planning Your Packaging For A Seamless Transition From Clinic To Launch")
Planning Your Packaging For A Seamless Transition From Clinic To LaunchExplore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
![iStock-1277730987-supply-chain-logistics-tracking-sourcing]( "Planning For The Return And Destruction Of Your Product")
Planning For The Return And Destruction Of Your ProductAspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.
-
![supply chain checklist pharmaceuticals-GettyImages-1616023386]( "Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It")
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes ItProtecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
![Singota-DSC03221]( "Developmental Testing Of IV Solutions")
Developmental Testing Of IV SolutionsAs IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.
-
![GettyImages-1368429013-vial]( "Overcoming Challenges In Cell And Gene Therapy Containment")
Overcoming Challenges In Cell And Gene Therapy ContainmentReview the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
![GettyImages-1173740564 data management]( "Navigating Audit Trail Data Regulations And Accessibility Changes")
Navigating Audit Trail Data Regulations And Accessibility ChangesData is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
![Quality Management GettyImages-1336716297]( "Quality Assured: Bringing Life-Changing Therapies To Patients")
Quality Assured: Bringing Life-Changing Therapies To PatientsBiopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
